Response to multiple glucose-lowering agents in a sib-pair with a novel HNF1α (MODY3) variant. [electronic resource]
- European journal of human genetics : EJHG 04 2020
- 518-520 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
1476-5438
10.1038/s41431-019-0561-8 doi
Adult Diabetes Mellitus, Type 2--drug therapy Dipeptidyl-Peptidase IV Inhibitors--therapeutic use Hepatocyte Nuclear Factor 1-alpha--genetics Humans Hypoglycemic Agents--therapeutic use Incretins--therapeutic use Male Mutation Pedigree Pharmacogenomic Variants Sulfonylurea Compounds--therapeutic use Treatment Outcome